Cell and Gene Therapy Conference

Clinical and Early Stage CAR T Cell and Gene Therapy Advances

• Push the boundaries of CD19 with solid tumours, combination therapies and safety switches
• Transition technologies from bench to bedside: CRISPR, Exosomes and more..
• Understand how to build a sustainable process early on for optimum clinical translation

Cell and Gene Therapy Bioprocessing

• Build a strategy for monitoring quality across your process with PAT and automated analytics
• Get to grips with technologies and novel platforms for efficient upstream and downstream processes
• Simplify manufacturing automation and prepare for commercialization

Cell & Gene Therapy Commercialization

• Work towards industry 4.0 – integrating manufacturing and delivery into healthcare
• Optimise the way you work with external partners to drive commercialization
• Ensure profitability with forward thinking in facility design and scalability strategies

Supply Chain Barriers: Upstream and Downstream Considerations

• Improve confidence in your raw material supply chain – vectors, risk mitigation and more
• Stay up to date on cryo considerations when moving from clinical to commercial phase manufacturing
• Prepare for successful delivery to patients & supply chain scale up

Cell and Gene Therapy Connect – Partnering Track

• Keep abreast of the evolving landscape of cell and gene therapies
• Tackle collaboration – new outsourcing models, when to make the decision to ‘spin out’ and more
• Dive into pharmacoeconomic approaches to reimbursement

Bio fabrication – The Path to Commercialization: With ARMI

•  Benefit from peer experience with automated manufacturing for Tissue Engineered Medical Products (TEMPs)
• Reduce COGS with modular processes & tools for manufacturing TEMPs at scale
• Be a part of the burgeoning supply chain for Tissue Engineered Medical Products industry